Relief for Cancer Patients: Revised MRPs on 1,364 Anti-Cancer Formulations Take Effect Today, Saving Consumers ₹3,540 Crore Annually
NEW DELHI — In a major relief for cancer patients and their families, revised Maximum Retail Prices (MRPs) for 1,364 anti-cancer formulations officially came into effect today.
The sweeping price revisions are expected to save consumers a staggering ₹3,540.38 crore annually, according to official government data.
The initiative stems from a directive by the National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
Following recommendations from an Expert Committee constituted by the Directorate General of Health Services (DGHS) on October 17, 2026, the NPPA capped trade margins on the MRPs of 137 critical anti-cancer drugs.
Highlighting the profound impact of this policy shift, a government spokesperson stated:
"This landmark intervention is a testament to our unwavering commitment to making essential life-saving treatments accessible and affordable for every citizen".
"With 85 pharmaceutical companies reporting revised MRPs covering 1,21 drugs—and more than half of those brands slashing prices by over 50%—we are alleviating a massive financial burden from cancer patients and their families."
Massive Price Reductions Across the Board
As of November 8, 2026, pharmaceutical companies moved swiftly to implement the regulatory caps. Out of the 1,364 formulations now under revised pricing:
679 brands have reported price reductions of more than 50%.
The highest reported reduction in MRP stands at a remarkable 96.45%, bringing previously exorbitant therapies within reach of common households.
"No chemist or hospital pharmacy is permitted to charge more than the revised MRP," the spokesperson emphasized. "We urge patients and caregivers to remain vigilant and report any discrepancies immediately."
How Consumers Can Verify Prices
The government has empowered consumers to verify medicine prices independently to ensure strict compliance at the retail level.
Patients and families can check the revised MRP printed directly on the medicine packaging or cross-verify prices through:
The Pharma Sahi Daam mobile application.
The official NPPA website
Grievance Redressal: Authorities have established robust mechanisms to crack down on overcharging.
In the event of any pricing-related grievance or overcharging by chemists or hospital pharmacies, consumers can register their complaints directly through the Pharma Jan Samadhan portal or reach out to the NPPA helpline.
